Atlas Trials

Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain

Clinical trial NCT06797817 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06797817
Sponsor
Universidad de Almeria
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer Disease (AD)
Start date
2026-06-01
Primary completion
2026-09-01
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.